Heterogeneity of paracetamol metabolism in Gilbert's syndrome

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 1, 1999, Pages 9-13

  Esteban, A ^a   Pérez Mateo, Miguel ^a,b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Gilbert's syndrome; Glucuronidation; Hepatotoxicity; Paracetamol conjugates; Paracetamol metabolism

Indexed keywords

ACETYLCYSTEINE; CYSTEINE; PARACETAMOL; PARACETAMOL GLUCURONIDE; PARACETAMOL SULFATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG ELIMINATION; DRUG METABOLISM; DRUG OXIDATION; DRUG URINE LEVEL; FEMALE; GILBERT DISEASE; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; ORAL DRUG ADMINISTRATION;

EID: 0345211459     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190005     Document Type: Article

References (30)

1. Thomson J.S., Prescott L.F. (1966) : Liver damage and impaired glucose tolerance after paracetamol overdose. BMJ 2: 506-507.
2. Mitchell J.R., Thorgeirsson S.S., Potter W.Z., Jollow D.J., Keiser H. (1974) : Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin. Pharmacol. Ther., 16: 676-684.
3. Prescott LF. (1983) : Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs, 25: 290-314.
4. Aono S., Adachi Y., Uyama E. et al. (1995) : Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet, 345: 958-959.
5. Ebner T., Burchell B. (1993) : Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab. Dispos., 21: 50-55.
6. Owens I.S., Ritter J.K. (1992) : The novel bilirubin/phenol UDP-glucuronosyltransferase UGT1 gene locus: implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes. Pharmacogenetics, 2: 93-108.
7. de Morais S.M.F., Wells P.G. (1989) : Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency. Hepatology, 10: 163-167
8. Schmid R., Hammaker L. (1959) : Glucuronide formation in patients with constitutional hepatic dysfunction (Gilbert's disease). N. Engl. J. Med., 260: 1310-1314.
9. Douglas A.P., Savage R.L., Rawlins M.D. (1978) : Paracetamol (Acetaminophen) kinetics in patients with Gilbert's syndrome. Eur. J. Clin. Pharmacol., 13: 209-212.
10. Ullrich D., Sieg A., Blume R., Bock K.W., Schröter W., Bircher J. (1987) : Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome. Eur. J. Clin. Invest., 17:237-240.
11. de Morais S.M.F., Uetrecht J.P., Wells P.G. (1992) : Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology, 102: 577-586.
12. Esteban A., Pérez-Mateo M. (1993) : Gilbert's disease: a risk factor for paracetamol overdosage? J. Hepatol., 18: 257-258.
13. Esteban A., Graells M., Satorre J., Pérez-Mateo M. (1992) : Determination of paracetamol and its four major metabolites in mouse plasma by reversed-phase ion-pair high-performance liquid chromatography. J. Chromatogr., 573: 121-126.
14. Critchley J.A.J.H, Nimmo G.R., Gregson C.A., Woolhouse N.M., Prescott L.F. (1986) : Inter-subject and ethnic differences in paracetamol metabolism. Br. J. Clin. Pharmacol., 22: 649-657.
15. Lee H.S., Ti T.Y., Koh Y.K., Prescott L.F. (1992) : Paracetamol elimination in Chinese and Indians in Singapore. Eur. J. Clin. Pharmacol., 43: 81-84.
16. Patel M., Tang B.K., Kalow W. (1992) : Variability of acetaminophen metabolism in Caucasians and Orientals. Pharmacogenetics, 2: 38-45.
17. Esteban A., Pérez-Mateo M. (1993) : El metabolismo del paracetamol en voluntarios sanos: estudio de una muestra en población española. Gastroenterol. Hepatol., 16: 55-60.
18. Esteban A., Calvo R., Pérez-Mateo M. (1996) : Paracetamol metabolism in two ethnically different Spanish populations. Eur. J. Drug Metab. Pharmacokinet., 21: 233-239.
19. Clements J.A., Critchley J.A.J.H., Prescott L.F. (1984) : The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. Br. J. Clin. Pharmacol., 18: 481-485.
20. Mucklow J.C, Fraser H.S., Bulpitt J., Kahn C., Mould G., Dollery C.T. (1980) : Environmental factors affecting paracetamol metabolism in London factory and office workers. Br. J. Clin. Pharmacol., 10: 67-74.
21. Prescott L.F. (1987) : Environmental modulation of paracetamol toxicity. In: Plaa G.L., Du Souich P., Erill S. (Eds) Interactions between drugs and chemicals in industrial societies. Esteve Foundation Symposia, vol 2. Amsterdam: Elsevier, 161-174.
22. Nash R.M., Stein L., Penno M.B., Passananti G.T., Vesell E.S. (1984) : Sources of interindividual variations in acetaminophen and antipyrine metabolism. Clin. Pharmacol. Ther., 36: 417-430.
23. Bosnia P.J., Chowdhury J.R., Huang T.J. et al. (1992) : Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J., 6: 2859-2863.
24. Ritter J.K., Yeatman M.T., Ferreira P., Owens I.S. (1992) : Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient. J. Clin. Invest., 90: 150-155.
25. Bosma P.J., Chowdhury J.R., Bakker C. et al. (1995) : The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med., 333: 1171-1175.
26. Mathew P. (1996) : The genetic basis of Gilbert's disease [comment]. N. Engl. J. Med., 334: 802-803.
27. Monaghan G., Ryan M., Seddon R., Hume R., Burchell B. (1996) : Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet, 347: 578-581.
28. Sato H., Adachi Y., Koiwai O. (1996) : The genetic basis of Gilbert's syndrome [comment]. Lancet, 347: 557-558.
29. Bock K.W., Forster A., Gschaidmeier H. et al. (1993) : Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem. Pharmacol., 45: 1809-1814.
30. Bock K.W., Schrenk D., Forster A. et al (1994) : The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics, 4: 209-218.